NEWS & EVENTS
Our Commitment
Precision Therapeutics is dedicated to the individualization of cancer treatment and the development and delivery of treatment support tools and services that assist physicians and benefit cancer patients.
Our commitment
More
ChemoFX logo and an image of a mother and her child Introducing a way to help treat
cancer without a single patient side effect.
And even more amazingly, without a single patient.


With the ChemoFx® Drug Response Marker, you can determine how chemotherapy will impact cancer cells before it impacts cancer patients. This simple test determines how a patient’s particular cells respond to different chemotherapies in the lab—not in the patient.
More
May 2009
ChemoFx® offers hope to cancer patients
March 2009>
Precision Quarterly Newsletter
November 10, 2008
Precision secures $43 million in funding